Terminalia brownii
Terminalia brownii · Accepted scientific name
Scientific literature: Sparse (63 studies) · ★★☆☆☆
, scientifically known as Terminalia brownii, is a significant medicinal tree native to various tropical regions. Renowned for its diverse therapeutic properties, the plant is frequently utilized in traditional medicine to treat ailments ranging from skin infections to gastrointestinal issues, offering valuable phytochemical compounds for modern pharmacological research and development.
- Family
- Combretaceae
- Native range
- Africa
- Parts used
- Leaf · Root
- Common names
- Not available
- Scientific synonyms
- Terminalia Brownii Var. Gallaensis · Terminalia Hemignosta · 5 more
Names and Synonyms
Scientific Names
Accepted name
Terminalia browniiSynonyms
- Terminalia brownii var. gallaensis
- Terminalia hemignosta
- Myrobalanus brownii
- Terminalia confertifolia
- Terminalia semlikiensis
- Terminalia brownii var. stenocarpa
- Terminalia brownii var. albertensis
Sources: Wikidata, Catalogue of Life
Taxonomical Classification
This plant belongs to the kingdom Plantae and is classified under the phylum Streptophyta and class Equisetopsida. Within the subclass Magnoliidae, it is organized under the order Myrtales and the family Combretaceae. Finally, it is identified by its genus, Terminalia, specifically as the species Terminalia brownii.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
This plant exhibits a broad geographical distribution across several key regions of the African continent. In West Tropical Africa, its presence is specifically noted within the borders of Nigeria. Moving into West-Central Tropical Africa, the species can be found in the Central African Republic, Cameroon, and the DR Congo. Additionally, its range extends into Northeast Tropical Africa, where it is located in Chad. Together, these locations highlight the plant's significance across diverse tropical environments.
| Region | Area |
|---|---|
| West Tropical Africa | Nigeria |
| West-Central Tropical Africa | Central African Republic |
| West-Central Tropical Africa | Cameroon |
| West-Central Tropical Africa | DR Congo |
| Northeast Tropical Africa | Chad |
| Northeast Tropical Africa | Djibouti |
| Northeast Tropical Africa | Eritrea |
| Northeast Tropical Africa | Ethiopia |
| Northeast Tropical Africa | Somalia |
| Northeast Tropical Africa | Sudan-South Sudan |
Sources: The World Checklist of Vascular Plants (WCVP)
Botanical Identification
Life history
The life history of Terminalia brownii is characterized by its status as a perennial species, allowing it to persist in its environment over many years. As a phanerophyte, it maintains its photosynthetic organs on elevated stems well above the ground level, establishing a structural presence within its ecosystem. Furthermore, the plant exhibits a deciduous nature, undergoing a seasonal shedding of its foliage as part of its natural growth and survival cycle.
- Deciduousness :
- deciduous
- Life form :
- phanerophyte
- Lifecycle :
- perennial
Morphology
The morphology of Terminalia brownii is characterized by a woody growth form, functioning as a self-supporting tree rather than a climber, vine, or liana. It is a terrestrial species that grows independently, neither acting as a parasite nor as an epiphyte. In terms of stature, the plant reaches a mean height of approximately 15 m, with recorded maximum heights reaching up to 12.19214826 m.
- Aquatic :
- terrestrial
- Climber :
- self-supporting
- Epiphyte :
- terrestrial
- Growth form :
- tree
- Parasite :
- independent
- Plant height max:
- 12.19214826 m
- Plant height mean:
- 15 m
- Woodiness :
- woody
Physiology
The physiology of Terminalia brownii is characterized by a standard C3 photosynthetic pathway, utilizing the Calvin cycle to fix atmospheric carbon dioxide during the light-independent reactions. This metabolic framework indicates that the plant's primary carbon assimilation occurs through the enzyme RuBisCO under typical atmospheric conditions, rather than employing specialized C4 or CAM mechanisms. Furthermore, the species does not function as a nitrogen fixer, meaning it lacks the specialized symbiotic relationships with diazotrophic bacteria, such as rhizobia, required to convert atmospheric nitrogen into bioavailable forms; instead, it relies on the uptake of nitrogenous compounds directly from the soil substrate to support its growth and metabolic processes.
- Nitrogen fixer :
- no
- Photosynthetic pathway :
- C3
Reproduction
The reproduction of Terminalia brownii is characterized by a biotic pollination syndrome, relying on living organisms to facilitate the transfer of pollen. Specifically, the plant utilizes insect pollination as its primary mechanism for fertilization. The resulting seeds exhibit a degree of morphological variability in terms of weight; the seed mass ranges from a minimum of 0.15773 g to a maximum of 0.69796 g, with an average seed mass of approximately 0.430563333 g.
- Pollination syndrome :
- insect
- Pollination syndrome :
- biotic
- Seed mass max:
- 0.69796 g
- Seed mass mean:
- 0.430563333 g
- Seed mass min:
- 0.15773 g
Sources: Global Inventory of Floras and Traits (GIFT)
Plant Parts
Terminalia brownii has 4 reported plant parts identified across 9 scientific publications and several other databases that are studied for medicinal purposes. The most consistently reported plant part include leaf, root, stem, seed.
| Plant part | Supporting sources | Consensus |
|---|---|---|
| Leaf | 4 supporting sources | ★★☆☆☆ |
| Root | 2 supporting sources | ★☆☆☆☆ |
| Stem | 2 supporting sources | ★☆☆☆☆ |
| Seed | 1 supporting sources | ★☆☆☆☆ |
Leaf
- Heliyon
- Frontiers in pharmacology
- Journal of parasitology research
- Pharmaceutics
Root
- BMC complementary and alternative medicine
- Pharmaceutics
Stem
- Natural product communications
- Pharmaceutics
Seed
- Heliyon
Chemicals
Terminalia brownii has 15 reported phytochemicals identified across 9 scientific publications and several other databases. The most consistently reported chemicals include DIHYDROACTINIDIOLIDE, ESCHWEILENOL C, Ellagitannins, Genipin, Leucodelphinidin.
| Chemical | Supporting sources | Consensus |
|---|---|---|
| DIHYDROACTINIDIOLIDE | 1 supporting sources | ★☆☆☆☆ |
| ESCHWEILENOL C | 1 supporting sources | ★☆☆☆☆ |
| Ellagitannins | 1 supporting sources | ★☆☆☆☆ |
| Genipin | 1 supporting sources | ★☆☆☆☆ |
| Leucodelphinidin | 1 supporting sources | ★☆☆☆☆ |
| Luteolin 7-O-glucoside | 1 supporting sources | ★☆☆☆☆ |
| MILTIODIOL | 1 supporting sources | ★☆☆☆☆ |
| Myricetin 3-rhamnoside | 1 supporting sources | ★☆☆☆☆ |
| Oleanane-type triterpenoid | 1 supporting sources | ★☆☆☆☆ |
| Papyriogenin D | 1 supporting sources | ★☆☆☆☆ |
DIHYDROACTINIDIOLIDE
- Journal of ethnopharmacology
ESCHWEILENOL C
- Malaria journal
Ellagitannins
- Pharmaceutics
Genipin
- Pharmaceutics
Leucodelphinidin
- Journal of ethnopharmacology
Luteolin 7-O-glucoside
- Pharmaceutics
MILTIODIOL
- Journal of ethnopharmacology
Myricetin 3-rhamnoside
- Pharmaceutics
Oleanane-type triterpenoid
- Natural product communications
Papyriogenin D
- Journal of ethnopharmacology
Activities
Terminalia brownii has 5 reported activities identified across 9 scientific publications and several other databases. The most consistently reported activities include Antimicrobial, Analgesic, Antifungal, Antiplasmodial, Antiulcer.
| Activity | Supporting sources | Consensus |
|---|---|---|
| Antimicrobial | 2 supporting sources | ★☆☆☆☆ |
| Analgesic | 1 supporting sources | ★☆☆☆☆ |
| Antifungal | 1 supporting sources | ★☆☆☆☆ |
| Antiplasmodial | 1 supporting sources | ★☆☆☆☆ |
| Antiulcer | 1 supporting sources | ★☆☆☆☆ |
Antimicrobial
- Heliyon
- Natural product communications
Analgesic
- Heliyon
Antifungal
- Pharmaceutics
Antiplasmodial
- Natural product communications
Antiulcer
- Heliyon
Conditions
Terminalia brownii has 22 reported investigations on conditions identified across 9 scientific publications and several other databases. The most consistently reported conditions include malaria, Escherichia coli, Plasmodium falciparum, Staphylococcus aureus, diarrhea.
| Condition | Supporting sources | Consensus |
|---|---|---|
| Malaria | 4 supporting sources | ★★☆☆☆ |
| Escherichia coli | 2 supporting sources | ★☆☆☆☆ |
| Plasmodium falciparum | 2 supporting sources | ★☆☆☆☆ |
| Staphylococcus aureus | 2 supporting sources | ★☆☆☆☆ |
| Diarrhea | 2 supporting sources | ★☆☆☆☆ |
| Fungal infections | 2 supporting sources | ★☆☆☆☆ |
| Bacillus anthracis | 1 supporting sources | ★☆☆☆☆ |
| Candida | 1 supporting sources | ★☆☆☆☆ |
| Candida albicans | 1 supporting sources | ★☆☆☆☆ |
| Cryptococcus neoformans | 1 supporting sources | ★☆☆☆☆ |
Malaria
- Biochemistry research international
- Malaria journal
- Journal of ethnopharmacology
- Journal of parasitology research
Escherichia coli
- BMC complementary and alternative medicine
- African journal of traditional, complementary, and alternative medicines : AJTCAM
Plasmodium falciparum
- Malaria journal
- Natural product communications
Staphylococcus aureus
- BMC complementary and alternative medicine
- African journal of traditional, complementary, and alternative medicines : AJTCAM
Diarrhea
- BMC complementary and alternative medicine
- Frontiers in pharmacology
Fungal infections
- BMC complementary and alternative medicine
- Pharmaceutics
Bacillus anthracis
- BMC complementary and alternative medicine
Candida
- Pharmaceutics
Candida albicans
- BMC complementary and alternative medicine
Cryptococcus neoformans
- BMC complementary and alternative medicine
Preparations
Terminalia brownii has 12 reported preparations identified across 9 scientific publications and several other databases. The most consistently reported preparations include 80% Methanol and Aqueous Bark Extracts, Extracts, acetone and methanol extracts of the roots, alcoholic extracts, aqueous extracts.
| Preparation | Supporting sources | Consensus |
|---|---|---|
| 80% methanol and aqueous bark extracts | 1 supporting sources | ★☆☆☆☆ |
| Extracts | 1 supporting sources | ★☆☆☆☆ |
| Acetone and methanol extracts of the roots | 1 supporting sources | ★☆☆☆☆ |
| Alcoholic extracts | 1 supporting sources | ★☆☆☆☆ |
| Aqueous extracts | 1 supporting sources | ★☆☆☆☆ |
| Decoctions and macerations of the leaves and stem bark | 1 supporting sources | ★☆☆☆☆ |
| Ethyl acetate extracts | 1 supporting sources | ★☆☆☆☆ |
| Ethyl acetate-soluble fraction of stem bark extract | 1 supporting sources | ★☆☆☆☆ |
| Fractions | 1 supporting sources | ★☆☆☆☆ |
| Leaf ethyl acetate extract | 1 supporting sources | ★☆☆☆☆ |
80% methanol and aqueous bark extracts
- Biochemistry research international
Extracts
- Malaria journal
Acetone and methanol extracts of the roots
- Pharmaceutics
Alcoholic extracts
- Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Aqueous extracts
- African journal of traditional, complementary, and alternative medicines : AJTCAM
Decoctions and macerations of the leaves and stem bark
- Pharmaceutics
Ethyl acetate extracts
- Journal of ethnopharmacology
Ethyl acetate-soluble fraction of stem bark extract
- Natural product communications
Fractions
- Malaria journal
Leaf ethyl acetate extract
- Pharmaceutics